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Background: Progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS)
affect speech and language as well as motor functions. Clinical and neuropathological
data indicate a close relationship between these two disorders and the non-fluent
variant of primary progressive aphasia (nfvPPA). We use the recently developed Mini
Linguistic State Examination tool (MLSE) to study speech and language disorders in
patients with PSP, CBS, and nfvPPA, in combination with structural magnetic resonance
imaging (MRI).
Methods: Fifty-one patients (PSP N = 13, CBS N = 19, nfvPPA N = 19) and 30
age-matched controls completed the MLSE, the short form of the Boston Diagnostic
Aphasia Examination (BDAE), and the Addenbrooke’s Cognitive Examination III. Thirty-
eight patients and all controls underwent structural MRI at 3 Tesla, with T1 and
T2-weighted images processed by surface-based and subcortical segmentation within
FreeSurfer 6.0.0 to extract cortical thickness and subcortical volumes. Morphometric
differences were compared between groups and correlated with the severity of speech
and language impairment.
Results: CBS and PSP patients showed impaired MLSE performance, compared
to controls, with a similar language profile to nfvPPA, albeit less severe. All patient
groups showed reduced cortical thickness in bilateral frontal regions and striatal volume.
PSP and nfvPPA patients also showed reduced superior temporal cortical thickness,
with additional thalamic and amygdalo-hippocampal volume reductions in nfvPPA.
Multivariate analysis of brain-wide cortical thickness and subcortical volumes with MLSE
domain scores revealed associations between performance on multiple speech and
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language domains with atrophy of left-lateralised fronto-temporal cortex, amygdala,
hippocampus, putamen, and caudate.
Conclusions: The effect of PSP and CBS on speech and language overlaps with
nfvPPA. These three disorders cause a common anatomical pattern of atrophy in
the left frontotemporal language network and striatum. The MLSE is a short clinical
screening tool that can identify the language disorder of PSP and CBS, facilitating clinical
management and patient access to future clinical trials.
Keywords: progressive supranuclear palsy, corticobasal syndrome, speech, language, aphasia
INTRODUCTION
Progressive supranuclear palsy (PSP) and corticobasal
degeneration are primary degenerative tauopathies affecting
movement and cognition (Litvan et al., 1996; Armstrong et al.,
2013; Burrell et al., 2014; Höglinger et al., 2017). Speech and
language deficits are common in both disorders, but their
recognition has been hampered by the lack of a brief but
sensitive clinical assessment tool (Peterson et al., 2019). In
this article, we use the Mini Linguistic State Examination
(MLSE; Patel et al., 2020) to investigate the range of speech and
language deficits in PSP and the corticobasal syndrome (CBS),
and their neural correlates in structural magnetic resonance
imaging (MRI).
The classical phenotype of PSP, Richardson’s syndrome, is
characterised by vertical supranuclear gaze palsy, axial rigidity,
and postural instability, with cognitive impairment (Steele
et al., 1964; Litvan et al., 1996). Richardson’s syndrome is
highly suggestive of PSP pathology, however, other common
phenotypes have been described, including a presentation
with speech and language deficits (PSP-SL; Respondek and
Höglinger, 2016; Höglinger et al., 2017). The clinical syndrome
of CBS is characterised by the combination of motor deficits
(progressive asymmetrical akinetic rigidity, dystonia, tremor,
myoclonus) and cortical features (alien limb, apraxia, cortical
sensory change; Riley and Lang, 1988; Boeve et al., 2003),
with heterogeneity in the clinical presentations and underlying
pathology (Armstrong et al., 2013; Alexander et al., 2014). CBS
is commonly accompanied by impaired speech and language
(Burrell et al., 2014; Peterson et al., 2019). Indeed, a non-fluent
agrammatic presentation of CBS (CBS-NAV) is recognised
in consensus clinical diagnostic criteria (Armstrong et al.,
2013). Speech and language deficits also develop commonly
in PSP and CBS after motor presentations (Catricalà et al.,
2019; Dodich et al., 2019; Peterson et al., 2019; Murley et al.,
2020).
The speech and language changes of PSP and CBS have much
in common with the non-fluent variant of a primary progressive
aphasia (nfvPPA). Indeed, there is considerable overlap in the
criteria for diagnosing nfvPPA, PSP-SL, and CBS-NAV (Peterson
et al., 2019). There is agrammatism, anomia, circumlocution, and
impaired syntactic comprehension in the context of preserved
single-word comprehension and object knowledge in patients
with PSP-SL and CBS-NAV (Armstrong et al., 2013; Höglinger
et al., 2017; Dodich et al., 2019), and subtle deficits in verbal
production and sentence comprehension in PSP/CBS (Dodich
et al., 2019). However, few studies have directly compared
speech and language in PSP/CBS with nfvPPA. Burrell et al.
(2018) found aphasic deficits on formal testing in PSP patients
that were comparable in frequency and severity to those of an
nfvPPA group. However, the PSP group were recruited mainly
from a cognitive disorders clinic and may have overrepresented
cognitive phenotypic presentations.
Although the speech and language changes of PSP and CBS
have similarities to nfvPPA, it does not necessitate a common
aetiology. However, there are overlapping neuropathological
features including neuronal, oligodendroglial, and astrocytic
inclusions that are immunoreactive for tau with 4 microtubule
binding repeats (4R; Grossman, 2010; Dickson et al., 2011;
Spinelli et al., 2017). PSP and CBS clinical signs often follow the
presentation of nfvPPA (Kertesz and McMonagle, 2010; Santos-
Santos et al., 2016; Cerami et al., 2017; Gazzina et al., 2019),
or primary progressive apraxia of speech (Josephs et al., 2014).
The clinical and pathological overlap of PSP, CBS, and nfvPPA
underlies the concept of a continuous spectrum of 4R-Tauopathy
disorders (Kertesz et al., 2005; Dickson et al., 2011; Murley et al.,
2020) that extends to the functional anatomy of their cognitive
deficits.
Here, we test the hypothesis that the three disorders have
a common associated structural impairment in relation to
their common effects on speech and language. The functional
anatomy of language impairment in PSP and CBS has been
identified by fluorodeoxyglucose positron emission tomography
(Dodich et al., 2019). Patients with language presentations of
these two conditions have hypometabolism in areas typical
of nfvPPA (left fronto-insular and superior medial frontal
cortex), whereas patients without language impairment showed
predominant right-hemispheric involvement. At the group
level, the disorders differ: PSP is associated with atrophy
and hypometabolism of midbrain, striatal, and frontal regions,
bilaterally (Kaat et al., 2011; Niccolini and Politis, 2016;
Murley et al., 2020); CBS is associated with asymmetric
hypometabolism and atrophy of frontoparietal cortex and basal
ganglia (Niccolini and Politis, 2016; Murley et al., 2020); and
nfvPPA is associated with atrophy and hypometabolism of
the left frontal perisylvian region, anterior insula, and frontal
operculum (Nestor et al., 2003; Gorno-Tempini et al., 2004; Preiß
et al., 2019).
The MLSE was recently developed as a screening tool
to identify and categorise speech and language deficits in
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neurological disorders (Patel et al., 2020). We, therefore, used
the MLSE to compare PSP, CBS, and nfvPPA. The speech and
language symptoms of PSP and CBS have been difficult to assess
and characterise in non-specialist settings because of the lack of
a validated brief language screening test. The MLSE is accurate
for the assessment of primary progressive aphasias (Patel et al.,
2020) but its performance in other neurological disorders is yet
to be assessed. We included patients with a range of PSP and CBS
phenotypic presentations to reflect the range of cases presenting
to cognitive and movement disorders clinics, noting that speech
and language impairment occurs in PSP/CBS patients even in
those who do not meet criteria for PSP-SL or CBS-NAV (Dodich
et al., 2019).
This study had two key aims: (1) to use the MLSE to evaluate
and compare linguistic impairment in PSP, CBS, and nfvPPA;
and (2) to investigate brain structural correlates of speech and
language deficits in PSP, CBS, and nfvPPA. We predicted that
the language profile in PSP and CBS would resemble that seen in
nfvPPA.We also predicted that performance on theMLSE would
be associated with cortical atrophy in a left-lateralised language
network, specifically, the inferior frontal cortex, associated with
agrammatic and apraxic speech (Gorno-Tempini et al., 2004).
MATERIALS AND METHODS
Ethics
Ethical approval was obtained from the London-Chelsea
Research Ethics Committee (REC reference: 16/LO/1735). The
study was sponsored by St. George’s, University of London. All
participants provided written informed consent.
Participants
Fifty-one patients (PSP N = 13, CBS N = 19, nfvPPA N = 19)
were recruited through specialist cognitive neurology clinics
at Addenbrooke’s Hospital, Cambridge (N = 33), St. George’s
Hospital, London (N = 13), and Manchester Royal Infirmary
and its associated clinical providers (N = 5). Patients were
included if they had a clinical diagnosis of PSP based on the
2017Movement Disorder Society criteria (Höglinger et al., 2017),
CBS based on the 2013 Armstrong et al. criteria (Armstrong et al.,
2013), or nfvPPA based on the 2011 Gorno-Tempini criteria
(Gorno-Tempini et al., 2011). Nine of the PSP patients had
probable PSP-Richardson’s syndrome; the other four included
one each of probable PSP-progressive gait freezing (PSP-PGF),
probable PSP-SL, possible PSP-ocular motor dysfunction (PSP-
OM), and possible PSP. Eight CBS patients had probable CBS; the
others had probable CBS-NAV (N = 6), possible CBS-NAV (1),
probable CBS presenting as PSP syndrome (CBS-PSP) (1), and
possible CBS (3). One nfvPPA patient declared a native language
other than English but had been highly fluent in English since
childhood and predominately used English in day-to-day life.
Patients were excluded if they had advanced dementia and were
unable to understand the purpose of the study or follow task
instructions. As part of their clinical assessment, PSP and CBS
patients completed the PSP Rating Scale (Golbe and Ohman-
Strickland, 2007). Medication information was also collected for
these groups.
Thirty healthy controls were recruited. Inclusion criteria for
the healthy control group were: the absence of a diagnosis of
any pathological process causing a cognitive disorder and/or
subjectively reported cognitive decline; age between 40 and
75 years; English as a first language; willing to participate in
a study investigating language and dementia. Healthy controls
were recruited through theNational Institute for Health Research
‘‘Join Dementia Research’’ register1 in Cambridge and London,
patients’ relatives, and via local advertisement.
Cognitive and Language Assessment
Participants completed the Addenbrooke’s Cognitive
Examination—III (ACE-III; Hsieh et al., 2013), the short form of
the Boston Diagnostic Aphasia Examination (BDAE; Goodglass
et al., 2001), and the Mini Linguistic State Examination (MLSE;
Patel et al., 2020). The short form of the BDAE, designed to assess
language changes after focal brain damage (mainly stroke), was
used to augment the MLSE assessment of language functions.
A composite score was calculated from the following subtests
of the short form of the BDAE, selected to overlap with the
MLSE subtasks: single word repetition (max = 5), basic word
discrimination (max = 16), sentence repetition (max = 2), the
Boston Naming Test short form (max = 15), and basic oral
word reading (max = 15), giving a maximum BDAE composite
score of 53 to compare with the MLSE total score. Assessment
sessions were video and/or audio recorded for offline scoring
and analysis.
The MLSE is a brief language assessment tool designed
for the assessment of progressive aphasia. It contains subtests
which span the principal linguistic domains affected by PPA,
as used to apply the diagnostic criteria (Gorno-Tempini et al.,
2011): confrontation naming, repetition, word and sentence
comprehension, semantic association, reading, writing and a
connected speech task. Error-based scoring provides domain
scores corresponding to key linguistic domains (motor speech,
knowledge of phonological structure, semantic knowledge,
syntactic knowledge, and auditory-verbal working memory) as
well as an overall total score out of 100, with lower scores
indicating poorer performance. TheMLSE has shown high inter-
rater agreement and diagnostic accuracy for the classification of
primary progressive aphasic syndromes (>90% accuracy using
random forest classification; Patel et al., 2020).
Data Management
Study data were collected and managed using the Research
Electronic Data Capture tool, a secure, web-based software
platform designed to support data capture for research studies,
hosted at the University of Cambridge and at St. George’s,
University of London (Harris et al., 2009, 2019).
Magnetic Resonance Imaging Protocol
Thirty-eight (PSP N = 11, CBS N = 14, nfvPPA N = 13) patients
and all controls underwent structural MRI at 3 Tesla with a
T1-weighted magnetisation-prepared rapid acquisition gradient
echo (MPRAGE) and T2-weighted sequences. Twenty-seven
1http://www.joindementiaresearch.nihr.ac.uk
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patients (PSP N = 9, CBS N = 9, nfvPPA N = 9) and 20 controls
were scanned at the Wolfson Brain Imaging Centre, University
of Cambridge on a Siemens Prisma 3T MRI (T1 Sagittal iPAT
2 parameters: TR = 2,000 ms, TE = 2.93 ms, TA = 306 s,
in-plane resolution = 1.1 × 1.1 mm, slice thickness = 1.1 mm,
Inversion Time = 850 ms, Flip Angle = 8◦; T2 Sagittal iPAT
2 parameters: TR = 3,200 ms, TE = 401 ms, TA = 283 s, in-plane
resolution = 1.1 × 1.1 mm, slice thickness = 1.1 mm, Inversion
Time = 850 ms, Flip Angle = 120◦). Eleven patients (PSP N = 2,
CBS N = 5, nfvPPA N = 4) and 10 controls were scanned at the
St. George’s Hospital Radiology Department on a Philips Achieva
3T MRI (T1 Sagittal SENSE parameters: TR = 6,600 – 6,900 ms,
TE = 3.0–3.2 ms, in-plane resolution = 1.1 × 1.1 mm, slice
thickness = 1.1 mm, Inversion Time = 850 ms, Flip Angle = 8◦;
T2 Sagittal SENSE parameters: TR = 2,200 ms, TE = 243 ms,
in-plane resolution = 1.1 × 1.1 mm, slice thickness = 1.1 mm,
Inversion Time = 850 ms, Flip Angle = 90◦). Three patients
were scanned at the Manchester Royal Infirmary site but were
not included in the MRI analysis in part because no healthy
volunteers were scanned at this site (i.e., unable to control for
an effect of scanner difference). The remaining 10 patients either
declined or were ineligible for MRI.
Analysis
Demographic, cognitive, and subcortical volumetric data were
analysed using RStudio and R version 4.0.2. A chi-square test
was conducted to investigate differences in sex distribution
between groups. Since Levene’s test showed that the variances
for years of education and ACE-III score were not equal,
Welch’s ANOVA with Games-Howell post hoc test was used.
Age, symptom duration, the BDAE composite score, MLSE
total and MLSE domain scores, and volumes of thalamus,
caudate, nucleus accumbens, and brainstem were not normally
distributed. Therefore, the Kruskal-Wallis rank sum test was
used, with post hoc pairwise comparisons by the Dunn test.
Multiple testing correction was conducted using the Benjamini-
Hochberg method (Benjamini and Hochberg, 1995). A corrected
value of p < 0.05 following Benjamini-Hochberg correction was
considered significant.
The T1- and T2-weighted images were processed using
FreeSurfer 6.0.0 recon-all pipeline. The T2 volume was used to
aid the definition of the pial surface. All images were reviewed
to confirm accurate segmentation. Group differences in cortical
thickness between each patient group and the control group were
tested using a univariate analysis with the group as a factor.
Sex and age were included as covariates of no interest. All tests
were performed vertex-wise subject to clusterwise correction
for multiple comparisons using FreeSurfer’s mri_glmfit-sim for
a permutation analysis with 10,000 randomisations and an
initial uncorrected height threshold of p< 0.01. Non-parametric
permutations analysis adequately controls for false positives at
this height threshold (Greve and Fischl, 2018).
We examined the relationship between language impairments
and imaging metrics using univariate and multivariate statistics.
The univariate approach tested the relationship between MLSE
total score and cortical thickness with gender and age as
covariates of no interest. Correlational analyses for cortical
thickness were performed at each vertex subject to clusterwise
correction formultiple comparisons using a permutation analysis
with 10,000 randomisations and an initial uncorrected height
threshold of p < 0.01. Clusters surviving a two-sided corrected
cluster threshold of p < 0.05 were deemed significant. To
investigate the link between MLSE and subcortical brain regions,
left and right subcortical structure volumes from FreeSurfer
were combined. Partial correlations were used to investigate
associations between volumes of subcortical structures with
MLSE total score, covarying estimated total intracranial volume,
age, and sex.
To assess themultivariate relationship betweenMLSE domain
scores and brain structures, we adopted a two-level procedure
(Tsvetanov et al., 2018, 2019; Passamonti et al., 2019). First,
canonical correlation analysis (Hotelling, 1936) identified the
linear relationship between the two multivariate datasets, namely
structural values (cortical thickness and subcortical volume)
and MLSE domain scores, providing pairs of latent variables
(Structure-LV and MLSE-LV). Each latent variable is a linear
combination of the original variables, optimised to maximise
the correlation between each pair. Here, dataset 1 consisted of
structural values of cortical thickness and subcortical volume
[67 subjects × 83 nodes: 68 from the Desikan-Killiany Atlas
and 15 (left and right: thalamus, caudate, putamen, pallidum,
hippocampus, amygdala, and nucleus accumbens; and the
brainstem) from the automatic subcortical segmentation atlas
within FreeSurfer (Fischl et al., 2002)], and dataset 2 included
MLSE domain scores (67 subjects × 5 domains). Covariates
of no interest included scanner site, gender, age, and total
intracranial volume. Next, we tested whether the identified
relationship between the cortical thickness and subcortical
volume profile (Structure-LV) and MLSE-LV was differentially
expressed by groups. We performed a second-level analysis
using multiple linear regression with a robust fitting algorithm
as implemented in the Matlab fitlm.m function. Independent
variables included subjects’ brain structure scores from first
level canonical correlation analysis, group information (patient
vs. control) and their interaction (Structure-LV × Group).
The dependent variable was subjects’ MLSE-LV scores




Fifty-one patients (PSP N = 13, CBS N = 19, nfvPPA N = 19) and
30 controls completed the language assessment, as summarised
in Table 1. The groups were similar in age and sex. The patient
groups showed similar symptom duration (F < 1). There was a
significant difference across the groups in years of education. Post
hoc pairwise comparisons indicated that the control group had
significantly more years of education than each patient group
(all p ≤ 0.003), but the patient groups did not differ from each
other on this variable. There was a significant difference across
the groups in ACE-III total score: higher in the control group
than each patient group (all p ≤ 0.001). In addition, the nfvPPA
mean ACE-III total score was lower than PSP (p = 0.019).
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Thirty-eight patients were included in the MRI analysis
protocol. We compared those included vs. not-included in the
MRI analysis in terms of demographic and cognitive measures
(Supplementary Table 1). The included patients had higher
ACE-III, BDAE composite, and MLSE total scores compared to
not-included patients, but the two groups did not differ in sex
distribution, age, years of education, or symptom duration.
Five (26%) CBS patients and six (46%) PSP patients were
taking dopaminergic medication. Using the Tomlinson et al.
(2010) formula, levodopa equivalent daily dose value for the CBS
patients was 193 mg (SD = 88.6) and for the PSP patients was
345 mg (SD = 254.1). 15% of PSP and 11% of CBS patients were
taking benzodiazepines, 23% of PSP and 11% of CBS patients
were taking opiates, 31% of PSP and 11% of CBS patients were
taking selective serotonin reuptake inhibitors, 31% of PSP and
11% of CBS patients were taking other antidepressants.
Language Scores
Figure 1 presents group performance for MLSE domains.
There were differences in scores between the groups for MLSE
total score (χ2(3) = 58.52, adjusted p < 0.001), motor speech
(χ2(3) = 48.90, adjusted p < 0.001), phonological structure
(χ2(3) = 47.56, adjusted p < 0.001), semantic knowledge
(χ2(3) = 39.40, adjusted p < 0.001), syntactic knowledge
(χ2(3) = 46.56, adjusted p < 0.001), and auditory-verbal
working memory (χ2(3) = 8.16, adjusted p = 0.043). Results
of post hoc pairwise comparisons using the Dunn test with
Benjamini-Hochberg adjustment (Benjamini and Hochberg,
1995) are presented in Figure 1.
Each patient group performed worse than controls for
MLSE total score and all MLSE subdomain scores apart from
auditory-verbal working memory (after correction for multiple
comparisons). The nfvPPA group scored lower than PSP and
CBS groups on MLSE total score, with no significant difference
between PSP and CBS. The PSP and CBS patients’ MLSE
subdomain scores were similar, while nfvPPA patients scored
significantly lower than CBS patients for motor speech, PSP
patients for semantic knowledge, and both PSP and CBS patients
for phonological structure and syntactic knowledge.
There was a significant difference in BDAE composite score
across the groups (χ2(3) = 46.63, corrected p < 0.001), with
the control group scoring significantly higher than each patient
group but with no significant differences between patient groups
(see Table 1).
MLSE scores were converted to per cent scores to visualise
the pattern of linguistic impairment across the groups. As shown
in Figure 2, the pattern of impairment on MLSE subdomains
is comparable across PSP, CBS and nfvPPA but with greater
severity in the nfvPPA patients.
Imaging Results
There were differences in cortical thickness between controls and
each patient group as shown in Figure 3A. All patient groups
showed bilateral cortical thinning in medial and lateral frontal
FIGURE 1 | Boxplots of group MLSE total and domain scores. The y-axes for each plot span the min to max scores. Significance markers represent adjusted p
values from post hoc pairwise comparisons using the Dunn test with Benjamini-Hochberg adjustment. “***” = adjusted p value < 0.001, “**” = adjusted p
value < 0.01, “*” = adjusted p value < 0.05.
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TABLE 1 | Demographic information for the study cohort.
Control CBS nfvPPA PSP Corrected P value
N 30 19 19 13 -
Sex (M/F) 18/12 11/8 7/12 8/5 0.452
Age
Mean (SD)
66.60 (4.33) 70.37 (7.71) 70.42 (6.95) 69.23 (6.03) 0.063
Education (years)
Mean (SD)
15.97 (3.33) 12.63 (2.83) 12.11 (2.16) 11.77 (1.74) <0.001
Symptom duration (months)
Mean (SD)
NA 49.47 (45.15) 35.63 (30.46) 45.62 (26.94) 0.590
ACE-III score
Mean (SD)
95.97 (3.47) 74.37 (17.90) 57.47 (22.13) 77.15 (13.30) <0.001
BDAE composite
Mean (SD)
52.68 (0.50) 47.42 (5.88) 39.29 (12.51) 46.58 (6.93) <0.001
PSP Rating Scale
Mean (SD)
– 29.28 (18.17) – 36.50 (16.15) -
Note: corrected P values are the result of Chi-squared, Welch’s ANOVA, or Kruskal-Wallis rank sum tests for each row with Benjamini-Hochberg adjustment.
FIGURE 2 | Radar plots showing percentage scores for MLSE subdomains.
FIGURE 3 | (A) Reduced cortical thickness in each patient group vs. the control group. Clusters show regions of significant reductions in cortical thickness between
each patient group and the controls following clusterwise correction at p < 0.05. (B) For visualisation purposes, the intersect of the clusters for the three group
comparisons of cortical thickness is shown. The intersect shows overlapping regions of reduced cortical thickness in the three patients vs. controls comparisons.
regions. The overlap between each patient-control cluster and
Desikan-Killiany atlas regions is presented in Table 2. We created
the intersect of the three patient-control analyses clusters to
illustrate the region of commonality using the ‘labels_intersect’
command in FreeSurfer (Figure 3B). Overlapping regions of
cortical thinning in the three patient groups encompassed
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inferior frontal, middle frontal, superior frontal, and precentral
gyri (Figure 3B). The PSP and nfvPPA groups additionally
showed cortical thinning in superior temporal regions, bilaterally
in PSP and left–sided in nfvPPA. Correlational analysis between
the MLSE total score and cortical thickness yielded no significant
clusters following clusterwise correction.
There were group differences in subcortical volumes as
shown in Table 3. All patient groups showed smaller putamen
compared to controls. In addition, PSP patients showed reduced
caudate volume compared to controls and reduced pallidum
volume compared to all other groups; and nfvPPA patients
showed reduced thalamus, caudate, and hippocampus volumes
compared to controls and reduced amygdala volume compared
to all other groups.
Partial correlations were conducted across the three patient
groups to examine relationships between subcortical volumes
and MLSE total score whilst controlling for estimated total
intracranial volume, age and sex. There was a significant positive
partial correlation between amygdala volume and MLSE total
score (r(33) = 0.377, N = 38, p = 0.026).
We assessed the multivariate relationship between MLSE
domain scores and structural scores (cortical thickness and
subcortical volumes) of 83 nodes across the brain using canonical
correlation analysis. We identified one significant pair of latent
variables (MLSE-LV and Structure-LV, r = 0.5731 p < 0.001;
Figure 4). The Structure-LV expressed the highest loadings
in the superior temporal cortex, prefrontal, inferior frontal
and precentral regions, amygdala, hippocampus, putamen, and
caudate, with a tendency for left lateralisation. The loading
values for all structures are presented in Supplementary Table
2. The MLSE-LV expressed all domains, with the highest
loadings on motor speech, phonology and syntax domains,
followed by semantic and auditory-verbal working memory
domains (Figure 4A). The positive loading values indicated
that higher performance on MLSE domains (more so motor
speech, phonology, and syntax domains) is associated with
greater cortical thickness in the frontotemporal regions shown
in Figure 4B and in volumes of the amygdala, hippocampus,
putamen and caudate (Figure 4C), with a tendency for
left lateralisation. The remaining four components were not
significant (p values 0.250, 0.432, 0.136, 0.430 for components
2–5, respectively).
To test whether the observed relationship between MLSE-LV
and Structure-LV is differentially expressed between controls and
patients, we constructed a second-level regression model with
robust error estimates by including Structure-LV subject scores,
group information and their interaction term as independent
variables and MLSE-LV as a dependent variable in addition to
covariates of no interest (Figure 4D). We found evidence for a
significant interaction (r = 0.562, p = 0.006) indicating a stronger
relationship between MLSE-LV and Structure-LV in the patients
relative to controls.
DISCUSSION
This study reveals the severity and structural correlates of
language impairment in PSP and CBS, using the Mini Linguistic
State Examination (MLSE). The PSP and CBS patients showed
impaired performance on the MLSE domains of motor speech,
phonological structure, semantic knowledge, and syntactic
knowledge, but not auditory-verbal working memory. This
pattern is similar to nfvPPA, consistent with previous reports of
CBS-NAV or PSP-SL (Burrell et al., 2018; Catricalà et al., 2019;
Dodich et al., 2019). PSP and CBS were similar to each other in
the severity and range of language impairment.
We identified brain structural correlates of MLSE
performance in PSP, CBS and nfvPPA. Multivariate analysis
confirmed the association between a language component based
on the MLSE domain scores (motor speech, phonology, and
syntax loading most strongly) and a structural component
(left-lateralised frontotemporal cortical thinning and subcortical
atrophy). Further, we found cortical thinning common to all
three patient groups in pre-frontal and precentral gyri. This
accords with previous research showing that motor speech,
phonology, and syntactic ability are the most affected linguistic
domains in PSP, CBS, and nfvPPA (Burrell et al., 2018; Dodich
et al., 2019; Peterson et al., 2019), and supports the sensitivity of
MLSE to structural changes associated with language effects of
PSP and CBS.
This atrophy is consistent with findings of hypometabolism
in the left inferior frontal gyrus in patients with PSP-SL and
CBS-NAV (Dodich et al., 2019), implicating this region in the
emergence of a nfvPPA-type language profile. Despite this
consistency, there is considerable heterogeneity in patterns
of structural and functional impairment in these disorders.
For example, some CBS patients show a pattern of language
impairment resembling the logopenic variant of PPA, with
impaired complex sentence repetition (Dodich et al., 2019),
together with bilateral parietal hypometabolism, possibly
reflecting underlying Alzheimer’s disease pathology rather than
corticobasal degeneration as the cause of CBS. Detailed analysis
of linguistic impairment at the individual level in conjunction
with pathological classification in PSP and CBS might provide
more insight into the clinical-anatomical correlates of language
impairment in these disorders.
The MLSE average assessment time was less than 20 min, but
this was sufficient to confirm mild to moderate impairment in
motor speech, semantic knowledge, phonological abilities, and
syntactic ability in PSP and CBS (Burrell et al., 2018; Peterson
et al., 2019). This confirms the MLSE as a quick language
screening tool for patients with mixed cognitive and movement
disorders. Many language tests assume good visual and motor
functions (e.g., tasks featuring visual stimuli or which require
writing). Such tasks might disadvantage PSP patients due to their
oculomotor abnormalities or disadvantage both PSP and CBS
patients due to motor deficits. This complicates interpretation
of results from investigations of language in these disorders
because scoring is often binary, the reasons for task failures
can be unclear and can differ across disorders (Peterson et al.,
2019; Picillo et al., 2019). The MLSE addresses this longstanding
issue by incorporating an error-based scoring system to capture
language-specific contributions to impaired test performance,
enabling one to tease apart linguistic deficits from one another
and from other impairments.
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TABLE 2 | The overlap between each patient-control cortical thickness analysis cluster with Desikan-Killiany atlas regions shown in area mm2 and percentage overlap.
Structure Name Hemisphere HC vs. CBS Cluster HC vs. PSP Cluster HC vs. nfvPPA Cluster
(Area mm2, %) (Area mm2, %) (Area mm2, %)
Frontal
Superior Frontal Left 3305, 50% 6322, 95% 3803, 57%
Right 3884, 61% 4549, 72% 3059, 48%
Rostral Middle Frontal Left 605, 13% 4549, 95% 1256, 26%
Right 1171, 24% 4840, 98% 365, 7%
Caudal Middle Frontal Left 1223, 57% 2072, 97% 1989, 93%
Right 1749, 88% 1902, 95% 1198, 60%
Pars Opercularis Left 660, 44% 1495, 100% 514, 34%
Right 618, 48% 1231, 96% 711, 56%
Pars Triangularis Left 216, 19% 1025, 92% 0
Right 0 805, 64% 0
Pars Orbitalis Left 0 259, 47% 0
Right 0 643, 95% 0
Lateral Orbitofrontal Left 0 1746, 82% 0
Right 0 1146, 53% 0
Medial Orbitofrontal Left 0 701, 46% 0
Right 0 813, 54% 0
Precentral Left 2698, 59% 4032, 88% 2951, 64%
Right 3610, 77% 4386, 94% 2738, 59%
Paracentral Left 332, 26% 538, 41% 505, 39%
Right 503, 33% 287, 19% 169, 11%
Frontal Pole Left 0 201, 100% 0
Right 0 238, 92% 0
Rostral Anterior Cingulate Left 0 350, 51% 245, 36%
Right 0 162, 30% 0
Caudal Anterior Cingulate Left 154, 24% 449, 69% 181, 28%
Right 49, 7% 185, 26% 52, 7%
Parietal
Superior Parietal Left 0 0 0
Right 0 0 0
Inferior Parietal Left 0 0 0
Right 0 289, 6% 0
Supramarginal Left 0 1071, 29% 0
Right 0 1270, 38% 0
Postcentral Left 0 1883, 47% 0
Right 0 2210, 58% 0
Precuneus Left 0 0 0
Right 0 0 0
Posterior Cingulate Left 401, 34% 260, 22% 340, 29%
Right 198, 17% 591, 50% 151, 13%
Isthmus Cingulate Left 103, 11% 0 0
Right 0 0 0
Temporal
Superior Temporal Left 0 1694, 50% 1910, 56%
Right 0 2422, 76% 0
Middle Temporal Left 0 0 216, 8%
Right 0 453, 15% 0
Inferior Temporal Left 0 0 600, 22%
Right 0 185, 7% 0
Banks of the Superior Temporal Sulcus Left 0 0 101, 10%
Right 0 565, 64% 0
Fusiform Left 0 0 469, 17%
Right 0 0 0
Transverse Temporal Left 0 433, 100% 280, 65%
Right 0 303, 100% 0
Entorhinal Left 0 0 224, 48%
Right 0 0 0
Temporal Pole Left 0 0 441, 94%
Right 0 232, 52% 0
Parahippocampal Left 0 0 0
Right 0 0 0
Insula Left 0 1715, 85% 294, 15%
Right 0 1606, 87% 229, 12%
(Continued)
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TABLE 2 | Continued
Structure Name Hemisphere HC vs. CBS Cluster HC vs. PSP Cluster HC vs. nfvPPA Cluster
(Area mm2, %) (Area mm2, %) (Area mm2, %)
Occipital
Lateral Occipital Left 0 0 0
Right 0 0 0
Lingual Left 0 0 0
Right 0 0 0
Cuneus Left 0 0 0
Right 0 0 0
Pericalcarine Left 0 0 0
Right 0 0 0
Note: only regions with >5% overlap are shown.
TABLE 3 | Subcortical volumes.
Control Mean (SD) PSP Mean (SD) CBS Mean (SD) nfvPPA Mean (SD)
Thalamus 13.33 (1.47) 12.73 (3.84) 12.06 (1.69) 11.74 (1.51)*
Caudate 6.85 (1.08) 6.01 (1.27)* 6.39 (1.15) 5.66 (0.82)*
Putamen 8.83 (1.05) 6.87 (1.11)* 7.85 (1.42)* 7.21 (1.00)*
Pallidum 3.79 (0.43) 2.86 (0.38)*,a,b 3.70 (0.51) 3.53 (0.54)
Hippocampus 8.06 (0.85) 7.50 (0.86) 7.40 (1.10) 7.11 (1.02)*
Amygdala 3.27 (0.45) 3.14 (0.38) 2.99 (0.46) 2.50 (0.47)*,a,c
Nucleus Accumbens 0.96 (0.13) 0.90 (0.35) 0.86 (0.18) 0.82 (0.17)
Brainstem 20.35 (2.17) 19.99 (4.87) 18.44 (2.17) 18.67 (2.85)
Note: volumes are presented in millilitres and left and right combined. Multiple testing correction was conducted using the Benjamini-Hochberg method (Benjamini and Hochberg,
1995). A corrected value of p < 0.05 was considered significant. *Significantly reduced vs. controls, asignificantly reduced vs. CBS, bsignificantly reduced vs. nfvPPA, csignificantly
reduced vs. PSP.
FIGURE 4 | (A) The MLSE latent variable (MLSE-LV) loadings. The MLSE-LV expressed all domains, with the highest loadings on motor speech, phonology and
syntax, followed by semantic and auditory-verbal working memory domains. (B) and (C) The Structure latent variable (Structure-LV) loadings. The Structure-LV
expressed high loadings in the superior temporal cortex, prefrontal, inferior frontal and precentral regions and in volumes of the amygdala, hippocampus, putamen
and caudate, with a tendency for left lateralisation. (D) Visualisation of the interaction effect and the relationship between the MLSE-LV and the Structure-LV in the
patients and controls. The relationship between MLSE-LV and Structure-LV was stronger in the patients relative to controls as visualised by black and orange
trendlines, respectively, and confirmed formally by a significant interaction term (r = 0.562, p = 0.006). Corticobasal syndrome (CBS), progressive supranuclear palsy
(PSP) and nfvPPA groups are colour coded.
There are limitations to the present study. We do
not have pathological validation in our sample although
clinicopathological correlations of PSP are very high (>90%;
Gazzina et al., 2019). We have not examined phenotypic variance
within groups other than language, due to the small group sizes
and insufficient power but note that PSP and CBS can represent
Frontiers in Aging Neuroscience | www.frontiersin.org 9 July 2021 | Volume 13 | Article 675739
Peterson et al. Language in PSP and CBS
diverse phenotypes. The small group sizes reflect the rarity of
these conditions and it may be due to type II error that we
were unable to detect between-patient-group differences in the
relationship between MLSE performance and brain structure.
Future studies with larger group sizes are needed to robustly
evaluate potential group-specific effects and to replicate our
findings. The study did not aim to dissect phenotype-specific
patterns of atrophy of linguistic impairment, but rather exploit
cohort variance to examine structure-function relationships. We
recognise a possible selection bias for the patients scanned, with
more severely impaired patients less likely to have undergone
MRI. This is supported by the poorer cognitive and language
performance in the patients who were not included in the MRI
analysis. Thus, our imaging results may be more reflective
of early-to-mid stage PSP/CBS/nfvPPA. Finally, the cross-
sectional nature of this study precludes an interpretation of the
progression of language profiles.
In conclusion, we find evidence for mild to moderate speech
and language deficits in PSP and CBS which are similar in profile
to nfvPPA. We have identified a shared anatomical substrate
that correlates with linguistic impairment across these disorders,
sensitive to MLSE profiling, consistent with the overlapping
clinical and pathological spectrum of PSP, CBS, and nfvPPA.
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